ARCHIVES

In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

July 29, 1988

Administration To Hold ASSIST Funding To ’92 Level; ACS Says Result Is Percent Cut

March 20, 1992

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988